Eliminate Coronary Artery Disease "ECAD"


Phase 2 Results N/A

Summary of Purpose

The purpose of this study is to determine whether pharmacologic lowering of low density lipoprotein cholesterol (LDL), initiated in healthy young to middle aged adults can eliminate or markedly reduce the composite endpoint of incident all cause mortality, myocardial infarction, stroke or coronary revascularization.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 May 2016.

1 Aug 2014 11 Sep 2014 1 Dec 2023 Unavailable 1 May 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment